[ad_1]
DALLAS, October 25, 2022 — Bruce Ovbiagele, MD, M.Sc., MAS, MBA, MLS, FAHA, has been appointed the new editor-in-chief of Journal of the American Heart Association (JAHA)a peer-reviewed open access journal published online by the American Heart Association, effective January 1, 2023. He replaces former Editor-in-Chief Barry London, MD, Ph.D., who has led the journal since November 2014. JAHA is the only online journal that publishes articles individually as they are accepted and compiles articles into 24 editions a year, twice every month.
“In 2014, Dr. Barry London entered and led JAHA, the first open access journal devoted to cardiovascular disease and brain health, and he continues to build on the vision of founding founder Dr. Joseph A. Vita. When JAHA celebrates 10th birthday this year, we are very grateful to Dr. London for his exemplary leadership that has been instrumental in the remarkable growth of JAHA, which now ranks in the top 30% of 143 journals in the Cardiac and Cardiovascular System category,” said Eldrin F. Lewis, MD, MPH, FAHA, chair of the Heart Association Scientific Publishing Committee. America, which oversees the Association’s 14 peer-reviewed scientific journals. “I am proud to announce Dr. Bruce Ovbiagele as new editor-in-chief for JAHAeffective January 1, 2023. Under Bruce’s leadership, I know this journal will continue to thrive in sharing the latest discoveries in cardiovascular disease and stroke prevention and treatment.”
Dr. Ovbiagele is a clinical epidemiologist, neurologist and global health expert focused on reducing the burden of stroke in the US and Sub-Saharan Africa. His work in the United States led to the discovery that middle-aged women have three times as many strokes as men of the same age, and additional research has linked stroke rates to the prevalence of type 2 diabetes and obesity. Dr Ovbiagele calls attention to adopting a healthy lifestyle as a means of stroke prevention, among many other benefits.
Internationally, he pioneered large-scale studies in Africa aimed at improving post-stroke outcomes and reducing barriers to treatment. He helped identify genetic variables that correlated with an increased chance of having a stroke for indigenous Africans. The first stroke prevention and control law enacted in Nigeria was based on the work of Dr. Ovbiagele to identify contextual stroke risk factors and develop awareness of stroke in the community. He is currently leading studies in Africa to improve clinical outcomes and reduce regional and racial disparities in stroke through the use of mobile health-based technologies, workforce shifting, and polypyle drug formulation. Its efforts are focused on making an impact where there is high penetration of mobile healthcare in many under-resourced areas, the brain drain of doctors in low-income countries and the need for cost-effective population-based strategies to prevent stroke in different populations.
Dr. Ovbiagele is a board-certified vascular neurologist and professor of neurology at the Weill Institute for Neuroscience at the University of California, San Francisco (UCSF). He is also associate dean and chief of staff at the San Francisco Veteran Affairs Health Care System (SFVAHCS). Additional roles include serving as professor at four universities abroad: University of Ibadan in Nigeria (medical); Kwame Nkrumah University of Science and Technology in Ghana (medicine); Capital Medical University/Xuan Wu Hospital in China (neurology); and Favaloro University/Instituto de Neurologia Cognitiva in Argentina (neurology).
“I am delighted to take on the role of editor-in-chief JAHA, said Dr. Ovbiagele. “With JAHA, I look forward to leveraging a great editorial team and promising publishing technology for the benefit of science, scientists and society, and the goal of creating a world with longer and healthier lives. However, leaving no one behind as we make and disseminate major scientific advances is very important, and fostering a more equitable environment is something I have always loved. The Association has done a lot of work to promote equity, and I am pleased to lead the journal into the next phase of growth as a respected international source of peer-reviewed cardiovascular research.”
Dr. Ovbiagele holds a Doctor of Medicine degree from the University of Lagos. He also holds a Master of Science in clinical research from the University of California, Los Angeles; a Master of Advanced Studies degree in health care leadership management from the University of California, San Diego; a Master of Business Administration degree from the University of Massachusetts; and a Masters in Law from the University of Washington, St. Louis. Dr. Ovbiagele completed his residency in neurology at the University of California, Irvine, and fellowship in vascular neurology at the University of California, Los Angeles. Prior to joining UCSF and SFVAHCS in 2018, he was a professor and chair of the department of neurology at the Medical University of South Carolina.
Dr. Ovbiagele is an elected member of the National Academy of Medicine and Association of American Physicians, as well as a Fellow of the Royal College of Physicians, and he has published more than 600 peer-reviewed research articles. His research and work has been recognized with various awards, including the 2022 Audrey Penn Award and Lecturer from the American Neurological Association, the 2022 Meritorious Achievement Award from the National Medical Association, the 2022 Robert Wartenberg Award and Lecturer from the American Academy of Neurology and the 2022 Mridha Spirit of Neurology Humanitarian Award from American Brain Foundation. Dr. Ovbiagele is listed in the 2022 global edition of 100 Nigerian Leading Transformational Change, of CHANGEMAKERS: Profiles and Biographies. He also serves on the editorial board Stroke Journalthat Journal of Stroke and Cerebrovascular Disease and Journal of Neurological Science.
From 2016-2018, Dr. Ovbiagele serves as chair of the American Heart Association International Stroke Conference, the premier gathering of stroke professionals from around the world, and previously served as associate editor for the Association’s journal. Blow, the leading journal in its field. He was previously recognized by the Association with the 2021 Stroke Council Awards and Lectures, the 2021 Ron Haddock International Impact Award and the 2021 William Feinberg Awards and Lectures.
The study published in the American Heart Association scientific journal was peer-reviewed. The statements and conclusions in each manuscript are those of the research authors and do not necessarily reflect the policies or positions of the Association. The Association makes no representations or warranties regarding its accuracy or reliability. The association receives funding primarily from individuals; foundations and companies (including pharmaceuticals, device manufacturers, and other companies) also make donations and fund the Association’s special programs and events. The Association has strict policies to prevent this relationship from affecting science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers as well as the Association’s overall financial information are available here.
Additional resources:
About the American Heart Association
The American Heart Association is a relentless force for a world with longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with many organizations, and supported by millions of volunteers, we fund innovative research, advocate for public health, and share life-saving resources. This Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.
###
For Media Inquiries: 214-706-1173; AHACommunications@heart.org
Michelle Kirkwood: 703-457-7838; Michelle.Kirkwood@heart.org
For Frequently Asked Questions: 1-800-AHA-USA1 (242-8721)
heart.org and stroke.org
[ad_2]
Source link